Parhofer KG, Pittrow D, Birkenfeld AL, Fraass U, Hohenstein B, Siegert C, Klotsche J, Steinhagen-Thiessen E, Dexl S, Schettler VJJ, Laufs U.
Clin Res Cardiol. 2026 Feb;115(2):288-303. doi: 10.1007/s00392-025-02719-z. Epub 2025 Aug 4. PMID: 40760109; PMCID: PMC12823742.
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies. Schäfer M, Strangfeld A.
Z Rheumatol. 2026 Feb;85(1):65-69. German. doi: 10.1007/s00393-025-01740-x. Epub 2025 Oct 20. PMID: 41114824; PMCID: PMC12872674.
Neue Erkenntnisse aus dem RABBIT-Register zum Krebsrisiko von Patient:innen mit rheumatoider Arthritis bei Therapie mit Januskinaseinhibitoren. [New results from the RABBIT register on the cancer risk of patients with rheumatoid arthritis treated with Janus kinase inhibitors]. Choy EH, Unizony SH, Wells AF, Dasgupta B, Buttgereit F, Tanaka Y.
Ann Rheum Dis. 2026 Jan;85(1):6-21. doi: 10.1016/j.ard.2025.09.005. Epub 2025 Oct 16. PMID: 41107118.
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment. Phithak E, Albach FN, Minopoulou I, Biesen R, Kleyer A, Wiebe E, Siegert E, Scholz V, Rehm M, Cheng Q, Sattler A, Bianco S, Fleischmann A, Hermann KG, Walter-Rittel T, Wagner M, Zernicke J, Casteleyn V, Nielsen M, Rose T, Busse A, Hütter-Krönke ML, Keller U, Schneider U, Kawelke L, Ruffer N, Stenzel W, Krönke G, Simon DN, Alexander A.
Ann Rheum Dis. 2026 Jan;85(1):212-215. doi: 10.1016/j.ard.2025.09.012. Epub 2025 Oct 23. PMID: 41130878.
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome. Wang Z, Dai X, Shu H, Yu S.
Immunol Invest. 2026 Jan;55(1):227-253. doi: 10.1080/08820139.2025.2576577. Epub 2025 Oct 27. PMID: 41143578.
Skin Immune Responses and Oncogenesis: A Delicate Balance. Proft F, Lembke S, Weiß A, Kellner H, Baraliakos X, Poddubnyy D, Regierer AC.
Rheumatology (Oxford). 2026 Jan 8;65(1):keaf641. doi: 10.1093/rheumatology/keaf641. PMID: 41335412; PMCID: PMC12822491.
Frequency of difficult-to-manage and treatment-refractory axial SpA: insights from the German RABBIT-SpA register using recent ASAS definitions. Thiele K, Albrecht KC, Veltri C, Karberg K, Köhler B, Callhoff J, Richter JG.
Semin Arthritis Rheum. 2026 Feb;76:152895. doi: 10.1016/j.semarthrit.2025.152895. Epub 2025 Dec 11. PMID: 41412093.
Trends in fatigue in inflammatory rheumatic diseases: Annual data and trajectory analysis of the German National Database 2007-2023. Chatzis L, Palamidas DA, Dörner T.
Curr Opin Immunol. 2026 Feb;98:102712. doi: 10.1016/j.coi.2025.102712. Epub 2025 Dec 23. PMID: 41435726.
Mapping the B-cell axis in Sjögren's disease: repertoire, microenvironment, and potential routes to precision treatment. Burt RK, Alexander T.
In: Dalakas MC [HRSG]: Immunotherapies for Neurologic Diseases; Handbook of Clinical Neurology Vol. 214. Amsterdam: Elsevier – Health Sciences Division; 2026; pp. 191-216. ISBN: 978-0-323-90887-0; doi: 10.1016/B978-0-323-90887-0.00020-1. PMID: 41526135.
Hematopoietic stem cell transplantation for multiple sclerosis: Improving understanding and addressing misconceptions.